This program is intended to explore current and novel health care delivery approaches and strategies for managing populations affected by cirrhosis and portal hypertension. In contrast to disease-based symposium focused on novel diagnostic and treatment approaches, this program intends to focus on current and evolving approaches inspired by delivery system reform to ensure that high quality, patient-centered, and resource efficien medical care is delivered to large segments of patients with advanced liver disease. The emphasis of this program is on clinical knowledge.Michael Volk Brett E.

Colleen N. Feriod, Andre Gustavo Oliveira, Mateus T. Guerra, Lily Nguyen, Kisha Mitchell Richards, Michael J. Jurczak, Hai‐Bin Ruan, Joao Paulo Camporez, Xiaoyong Yang, Gerald I. Shulman, Anton M. Bennett, Michael H. Nathanson, Barbara E. Ehrlich – 11 November 2016 – Fatty liver is the most common type of liver disease, affecting nearly one third of the U.S. population and more than half a billion people worldwide. Abnormalities in endoplasmic reticulum (ER) calcium handling and mitochondrial function each have been implicated in abnormal lipid droplet formation.

William Bernal – 10 November 2016

James Hamilton, Svetlana Lutsenko – 10 November 2016

Lin Wang, Jiabao Geng – 10 November 2016

Ahmed Akhter, Abhishek Pulla, Adnan Said – 10 November 2016

Ahad Eshraghian – 10 November 2016

Marloes van Asten, Pauline Verhaegh, Ger Koek, Jef Verbeek – 10 November 2016

Colin J. McCarthy, Ashraf Thabet, Kei Yamada, Peter R. Mueller, Parsia A. Vagefi – 10 November 2016

Neil D. Shah, Michael W. Fried – 10 November 2016